Covid-19: Clinical trials of Covaxin to start at Bhubaneswar from July 22

The special laboratory -- Preventive and Therapeutic Clinical Trial Unit (PTCTU) -- was inaugurated at the institute on Monday by its dean Gangadhar Sahoo

Human clinical trials of the country's indigenously developed Covid-19 vaccine is set to begin this week at a Bhubaneswar-based institute -- one of the 12 centres selected by the ICMR for conducting phase one and two of the process, a senior official said.

The human trials of BBV152 Covid Vaccine or Covaxin will begin on Wednesday in a special laboratory set up at the Institute of Medical Sciences and SUM (IMS & SUM) Hospital, in accordance with the protocols laid down by the Drugs Controller General of India (DCGI), the official at the facility here said.

The special laboratory --